POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
PR Newswire•19/10/2026•08:30 ET
0
Key Highlights
- ➤ADR program terminates before October 21, 2026 market open
- ➤Each ten ADSs exchange for three post-consolidation Class A shares
- ➤Every ten ordinary shares consolidate into one share of the same class
- ➤Class A shares begin Nasdaq trading October 21 under POM, CUSIP G7166T112
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq PR Newswire
GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it has commenced to terminate its American Depositary Receipt program (the "ADR Program"), including the termination of the related deposit agreement, as amended, and list the Company's Class A ordinary shares directly on The Nasdaq Stock Market LLC ("Nasdaq").
Get started
Create a free account to read the full story.